文献速递乳腺技术与安全US

超声微血流评估鉴别乳腺实性肿块良恶性的前瞻性研究:超声参数与组织学微血管密度的关联

A Prospective Study on the Value of Ultrasound Microflow Assessment to Distinguish Malignant from Benign Solid Breast Masses: Association between Ultrasound Parameters and Histologic Microvessel Densities.
PubMed 文献 · Korean J Radiol · 2019-01-01

前瞻性纳入98个乳腺实性肿块(良性57个、恶性41个),活检前用SMI和CEUS评估血管参数并与组织学MVD对照。恶性肿块SMI血管指数更高、血管形态更复杂、中央血管性和穿通血管更常见,CEUS峰值强度、斜率、面积更高,且灌注缺损更多;SMI与CEUS的AUC分别为0.853和0.841,差异无统计学意义。超声血管参数与组织学MVD相关。

要点

  • SMI上恶性肿块血管指数15.1±7.3 vs 良性5.9±5.6,复杂血管形态82.9% vs 42.1%,中央血管性95.1% vs 59.6%,穿通血管80.5% vs 31.6%(均p<0.001)。
  • CEUS上恶性肿块峰值强度37.1±25.7 vs 17.0±15.8、斜率10.6±11.2 vs 3.9±4.2、面积1035.7±726.9 vs 458.2±410.2,灌注缺损31.7% vs 3.5%(p≤0.023)。
  • SMI与CEUS的AUC分别为0.853和0.841(p=0.803);结合SMI良性参数后12个BI-RADS 4A肿块可避免不必要的活检,AUC由0.500提高至0.605(p<0.001)。

核心结论

  • SMI和CEUS的超声微血流评估有助于鉴别乳腺实性肿块良恶性,超声血管参数与组织学MVD相关。

研究设计与样本

  • 前瞻性研究,纳入98个乳腺实性肿块(良性57个、恶性41个),活检前行SMI和CEUS检查,由2名放射科医师评估血管参数,并以组织学MVD为参照。

关键影像表现/征象

  • SMI上恶性肿块血管指数15.1±7.3 vs 良性5.9±5.6,复杂血管形态82.9% vs 42.1%,中央血管性95.1% vs 59.6%,穿通血管80.5% vs 31.6%(均p<0.001)。
  • CEUS上恶性肿块峰值强度37.1±25.7 vs 17.0±15.8(p<0.001)、斜率10.6±11.2 vs 3.9±4.2(p=0.001)、面积1035.7±726.9 vs 458.2±410.2(p<0.001)、高增强95.1% vs 70.2%(p=0.005)、向心性增强70.7% vs 45.6%(p=0.023)、穿通血管65.9% vs 22.8%(p<0.001)、灌注缺损31.7% vs 3.5%(p<0.001)。
  • 在19个<10 mm的肿块中,SMI中央血管性与恶性相关(100% vs 38.5%,p=0.018)。

诊断标准与关键数值

  • SMI诊断恶性AUC为0.853,CEUS诊断恶性AUC为0.841,两者比较p=0.803。
  • 结合SMI良性参数后,12个BI-RADS 4A肿块可避免不必要的活检,AUC由0.500提高至0.605(p<0.001)。
  • 与恶性相关的超声血管参数对应更高的组织学MVD(p≤0.016);恶性肿块MVD高于良性肿块,雌激素受体阴性或Ki67阳性的恶性肿块MVD更高(p<0.05)。

临床应用与阅片要点

  • SMI和CEUS的微血流参数可用于辅助鉴别乳腺实性肿块的良恶性,血管指数、复杂血管形态、中央血管性、穿通血管及CEUS灌注缺损等参数在恶性肿块中更常见。
  • 对<10 mm的小肿块,SMI中央血管性可能与恶性相关,阅片时可关注该征象。
  • 对BI-RADS 4A肿块,结合SMI良性血管参数可能有助于减少不必要的活检。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the value of ultrasound (US) microflow assessment in distinguishing malignant from benign solid breast masses as well as the association between US parameters and histologic microvessel density (MVD).

MATERIALS AND METHODS: Ninety-eight breast masses (57 benign and 41 malignant) were examined using Superb Microvascular Imaging (SMI) and contrast-enhanced US (CEUS) before biopsy. Two radiologists evaluated the quantitative and qualitative vascular parameters on SMI (vascular index, morphology, distribution, and penetration) and CEUS (time-intensity curve analysis and enhancement characteristics). US parameters were compared between benign and malignant masses and the diagnostic performance was compared between SMI and CEUS. Subgroup analysis was performed according to lesion size. The effect of vascular parameters on downgrading Breast Imaging Reporting and Data System (BI-RADS) category 4A masses was evaluated. The association between histologic MVD and US parameters was analyzed.

RESULTS: Malignant masses were associated with a higher vascular index (15.1 ± 7.3 vs. 5.9 ± 5.6), complex vessel morphology (82.9% vs. 42.1%), central vascularity (95.1% vs. 59.6%), penetrating vessels (80.5% vs. 31.6%) on SMI (all, p < 0.001), as well as higher peak intensity (37.1 ± 25.7 vs. 17.0 ± 15.8, p < 0.001), slope (10.6 ± 11.2 vs. 3.9 ± 4.2, p = 0.001), area (1035.7 ± 726.9 vs. 458.2 ± 410.2, p < 0.001), hyperenhancement (95.1% vs. 70.2%, p = 0.005), centripetal enhancement (70.7% vs. 45.6%, p = 0.023), penetrating vessels (65.9% vs. 22.8%, p < 0.001), and perfusion defects (31.7% vs. 3.5%, p < 0.001) on CEUS (p ≤ 0.023). The areas under the receiver operating characteristic curve (AUCs) of SMI and CEUS were 0.853 and 0.841, respectively (p = 0.803). In 19 masses measuring < 10 mm, central vascularity on SMI was associated with malignancy (100% vs. 38.5%, p = 0.018). Considering all benign SMI parameters on the BI-RADS assessment, unnecessary biopsies could be avoided in 12 category 4A masses with improved AUCs (0.500 vs. 0.605, p < 0.001). US vascular parameters associated with malignancy showed higher MVD (p ≤ 0.016). MVD was higher in malignant masses than in benign masses, and malignant masses negative for estrogen receptor or positive for Ki67 had higher MVD (p < 0.05).

CONCLUSION: US microflow assessment using SMI and CEUS is valuable in distinguishing malignant from benign solid breast masses, and US vascular parameters are associated with histologic MVD.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Park AY, Kwon M, Woo OH, et al. A Prospective Study on the Value of Ultrasound Microflow Assessment to Distinguish Malignant from Benign Solid Breast Masses: Association between Ultrasound Parameters and Histologic Microvessel Densities. Korean J Radiol. 2019. PMID: 30993927. doi:10.3348/kjr.2018.0515

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。